Exchange: NYSE·Updated 09:08 AM EDT
A logo

A Agilent Technologies Inc.

$182.40
$1.25
(0.69%)
Pre-Market
Prev Close $181.15
EarningsNov 23
Mkt Cap$51.07B
Vol379.00

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
41

Bearish Sentiment

How do you feel about A?

RenkoTradingSystem
$A A (Weekly & 195-Min Renko) System Status: GO (2nd Green Brick Confirmed) Setup Trigger (195-Min Renko) 2nd Green Brick Confirmed: Printed cleanly at $171.27, holding above PSAR support ($166.08) and 20-EMA ($165.09). StochRSI: Hooking upward out of oversold territory (0.301), signaling fresh momentum expansion. Extension Filter: Price is safely within range at ~3.7% above the 195-min 20-EMA. Higher-Timeframe Support (Weekly) Weekly RSI(14): 69.02, reflecting robust long-term buying pressure without being overbought. Macro Structure: SCTR sits at an elite 95.0. Price cleanly holds above rising 10-EMA ($160.18) and 20-EMA ($150.34) with weekly Renko back in green. The Takeaway: Agilent satisfies all primary system criteria for a high-probability long entry. Clear runway to earnings on November 25, 2026. Execution Checklist Entry: Buy zone ~$171.27–$172.50 Hard Stop Loss: $166.00 (below 195-min PSAR support) Invalidation: Close position if 195-min red brick prints below $166.08
1
optik
$A rmbr my prevision 112 to 150/160 ,today 186 , Ecolab 245 today 303. performer the market. only Camtek not go well, for the moment.
astuteoptics1
$A Agilent Technologies sits at $172.97 with a trailing GAAP P/E of 34.0x against a peer median of 40.8x, anchored by an ROE of 19.6% and an operating margin of 22.2%. Fundamentals are supported by a Q3 beat and raised fiscal 2026 EPS guidance of $6.18 to $6.21, alongside a net debt position of $2.2B against $1.6B of fiscal 2025 operating cash flow. Technically, the shares trade above the 20-day moving average of $170.55, the 50-day moving average of $158.89, and the 200-day moving average of $134.50. Sentiment is backed by short interest falling 8% month-over-month to 1.9% of float and 7 of the 10 largest institutional holders adding to their positions. What would change our mind: a break below the 200-day moving average or weaker China orders. (Disclosure: we're and this is our own research.)
RenkoTradingSystem
$A (Agilent Technologies): System Health Check (10/22) Verdict: Watchlist, no entry yet. A is one of the cleaner setups so far. The weekly structure, sector, and SCTR all pass, and the rally was under the 8-green limit. The pullback is just starting. What you need to see: A 2-3 red brick pullback, ideally touching the 20 EMA (about 170.01). RSI near 45-50, and StochRSI turning up from below 0.20. A 1st green, then a 2nd green that breaks above the pullback resistance. A 6th red, or a break below 165.30, cancels the setup. Send fresh charts when a green brick prints.
MarkNewtonCMT
Agilent Tech ($A) pushing up aggressively in recent mths following five yrs of lifeless consolidation. Stocks like these hitting multi-year highs following massive bases are always worth keeping on the "front burner" when the sector is starting to accelerate after having trended down relatively for 3 years. Agilent not really Med-Tech nor biotech but more Life Sciences which has really begun to kick into gear lately I list my top Technical ideas within this sub-sector in tonight's report Charts via #IBD and #IBDPartner
RenkoTradingSystem
$A Two Green Bricks on the 195-Minute 1% Renko Chart. The only thing stopping me from going long is the Weekly 1% Renko chart which has a Red Brick. It will take a +2.04% ($3.43) move higher to turn the Weekly Red Brick to a Green Brick. Weekly RSI Analysis Current Reading: RSI 68.54 Health Check: PASS. Under the system rules a RSI of 68.54 sits in the optimal trend expansion zone. It indicates strong bullish momentum without being in extreme overbought territory (>80). A's Industry (Medical Equipment) just broke out of a month long consolidation.

Advertisement|Remove ads.